Cells,
Journal Year:
2025,
Volume and Issue:
14(2), P. 98 - 98
Published: Jan. 10, 2025
Doxorubicin
is
a
highly
effective
anticancer
agent,
but
its
clinical
use
restricted
by
severe
side
effects,
including
atherosclerosis
and
cardiomyopathy.
These
complications
are
partly
attributed
to
doxorubicin's
ability
induce
endothelial-to-mesenchymal
transition
(EndMT)
in
vascular
endothelial
cells,
critical
process
the
initiation
progression
of
GV1001,
multifunctional
peptide
with
anti-inflammatory,
anti-cancer,
antioxidant,
anti-Alzheimer's
properties,
has
demonstrated
inhibition
EndMT.
We
investigated
whether
GV1001
could
counteract
doxorubicin-induced
EndMT
cells
prevent
mouse
model.
The
results
revealed
that
significantly
suppressed
induced
doxorubicin,
likely
through
protective
effects
on
mitochondria.
By
mitigating
mitochondrial
damage,
reduced
accumulation
cellular
reactive
oxygen
species
(ROS),
repressed
activation
nuclear
factor
kappa
B
(NF-κB),
production
proinflammatory
cytokines
cells.
Additionally,
systemic
inflammation,
lipid
accumulation,
monocyte/macrophage
infiltration
within
arterial
walls
mice.
In
conclusion,
appears
safeguarding
from
dysfunction,
phenotypic
changes.
findings
suggest
potential
as
therapeutic
agent
mitigate
long-term
cardiovascular
associated
doxorubicin
treatment
humans.
Biomolecules,
Journal Year:
2020,
Volume and Issue:
10(10), P. 1429 - 1429
Published: Oct. 9, 2020
Glutathione
(GSH)
is
the
most
abundant
non-protein
thiol
present
at
millimolar
concentrations
in
mammalian
tissues.
As
an
important
intracellular
antioxidant,
it
acts
as
a
regulator
of
cellular
redox
state
protecting
cells
from
damage
caused
by
lipid
peroxides,
reactive
oxygen
and
nitrogen
species,
xenobiotics.
Recent
studies
have
highlighted
importance
GSH
key
signal
transduction
reactions
controller
cell
differentiation,
proliferation,
apoptosis,
ferroptosis
immune
function.
Molecular
changes
antioxidant
system
disturbances
homeostasis
been
implicated
tumor
initiation,
progression,
treatment
response.
Hence,
has
both
protective
pathogenic
roles.
Although
healthy
crucial
for
removal
detoxification
carcinogens,
elevated
levels
are
associated
with
progression
increased
resistance
to
chemotherapeutic
drugs.
Recently,
several
novel
therapies
developed
target
tumors
means
response
decreased
drug
resistance.
In
this
comprehensive
review
we
explore
mechanisms
functionalities
different
therapeutic
approaches
that
either
directly,
indirectly
or
use
GSH-based
prodrugs.
Consideration
also
given
computational
methods
used
describe
related
processes
silico
testing
effects.
Theranostics,
Journal Year:
2021,
Volume and Issue:
11(10), P. 4839 - 4857
Published: Jan. 1, 2021
Reactive
oxygen
species
(ROS)
serve
as
cell
signaling
molecules
generated
in
oxidative
metabolism
and
are
associated
with
a
number
of
human
diseases.
The
reprogramming
redox
induces
abnormal
accumulation
ROS
cancer
cells.
It
has
been
widely
accepted
that
play
opposite
roles
tumor
growth,
metastasis
apoptosis
according
to
their
different
distributions,
concentrations
durations
specific
subcellular
structures.
These
double-edged
progression
include
the
ROS-dependent
malignant
transformation
stress-induced
death.
In
this
review,
we
summarize
notable
literatures
on
generation
scavenging,
discuss
related
signal
transduction
networks
corresponding
anticancer
therapies.
There
is
no
doubt
an
improved
understanding
sophisticated
mechanism
biology
imperative
conquer
cancer.
Redox Biology,
Journal Year:
2020,
Volume and Issue:
37, P. 101696 - 101696
Published: Aug. 27, 2020
Reactive
oxygen
species
(ROS)
are
critical
for
the
progression
of
cardiovascular
diseases,
inflammations
and
tumors.
However,
mechanisms
how
ROS
sense
metabolic
stress,
regulate
pathways
initiate
proliferation,
inflammation
cell
death
responses
remain
poorly
characterized.
In
this
analytic
review,
we
concluded
that:
1)
Based
on
different
features
functions,
eleven
types
can
be
classified
into
seven
functional
groups:
stress-sensing,
chemical
connecting,
organelle
communication,
stress
branch-out,
inflammasome-activating,
dual
functions
triple
ROS.
2)
Among
generation
systems,
mitochondria
consume
most
amount
oxygen;
nine
generated;
thus,
mitochondrial
systems
serve
as
central
hub
connecting
with
inflammasome
activation,
trained
immunity
immunometabolic
pathways.
3)
Increased
nuclear
production
significantly
promotes
in
comparison
to
that
other
organelles.
Nuclear
a
convergent
decision-makers
connect
unbearable
alarming
stresses
death.
4)
Balanced
levels
indicate
physiological
homeostasis
various
processes
subcellular
organelles
cytosol,
while
imbalanced
present
alarms
pathological
processes.
these
analyses,
propose
working
model
new
integrated
network
sensing
Our
provides
novel
insights
roles
bridging
inflammation,
tumorigenesis;
provide
therapeutic
targets
treating
those
diseases.
(Word
count:
246).
Cell Death and Differentiation,
Journal Year:
2022,
Volume and Issue:
29(7), P. 1304 - 1317
Published: July 1, 2022
Abstract
During
decades,
the
research
field
of
cancer
metabolism
was
based
on
Warburg
effect,
described
almost
one
century
ago.
Lately,
key
role
mitochondria
in
development
has
been
demonstrated.
Many
mitochondrial
pathways
including
oxidative
phosphorylation,
fatty
acid,
glutamine,
and
carbon
are
altered
tumors,
due
to
mutations
oncogenes
tumor
suppressor
genes,
as
well
metabolic
enzymes.
This
results
reprogramming
that
sustains
rapid
cell
proliferation
can
lead
an
increase
reactive
oxygen
species
used
by
cells
maintain
pro-tumorigenic
signaling
while
avoiding
cellular
death.
The
knowledge
acquired
importance
is
now
being
translated
into
clinical
practice.
Detailed
genomic,
transcriptomic,
metabolomic
analysis
tumors
necessary
develop
more
precise
treatments.
successful
use
drugs
targeting
enzymes
highlighted
potential
for
their
precision
medicine
many
therapeutic
candidates
trials.
However,
efficient
personalized
proved
challenging
combination
with
other
strategies
such
chemocytotoxic
drugs,
immunotherapy,
ketogenic
or
calorie
restriction
diets
likely
boost
potential.
In
this
review,
we
summarize
main
features,
pathways,
alterations
different
types.
We
also
present
overview
current
inhibitors,
highlight
attractive
targets,
discuss
challenges
translation
these
approaches
indisputable
presents
several
targets
both
tailored
therapy.
Antioxidants,
Journal Year:
2022,
Volume and Issue:
11(6), P. 1128 - 1128
Published: June 8, 2022
Cancer
is
characterized
by
increased
oxidative
stress,
an
imbalance
between
reactive
oxygen
species
(ROS)
and
antioxidants.
Enhanced
ROS
accumulation,
as
a
result
of
metabolic
disturbances
signaling
aberrations,
can
promote
carcinogenesis
malignant
progression
inducing
gene
mutations
activating
pro-oncogenic
signaling,
providing
possible
rationale
for
targeting
stress
in
cancer
treatment.
While
numerous
antioxidants
have
demonstrated
therapeutic
potential,
their
clinical
efficacy
remains
unproven.
Here,
we
review
the
for,
recent
advances
in,
pre-clinical
research
on
antioxidant
therapy
cancer,
including
with
nonenzymatic
antioxidants,
such
NRF2
activators,
vitamins,
N-acetylcysteine
GSH
esters,
or
enzymatic
NOX
inhibitors
SOD
mimics.
In
addition,
will
offer
insights
into
prospective
options
improving
effectiveness
therapy,
which
may
expand
its
applications
Journal of Medicinal Chemistry,
Journal Year:
2023,
Volume and Issue:
66(17), P. 11632 - 11655
Published: Aug. 31, 2023
NADPH
oxidases
(NOXs)
form
a
family
of
electron-transporting
membrane
enzymes
whose
main
function
is
reactive
oxygen
species
(ROS)
generation.
Strong
evidence
suggests
that
ROS
produced
by
NOX
are
major
contributors
to
oxidative
damage
under
pathologic
conditions.
Therefore,
blocking
the
undesirable
actions
these
therapeutic
strategy
for
treating
various
pathological
disorders,
such
as
cardiovascular
diseases,
inflammation,
and
cancer.
To
date,
identification
selective
inhibitors
quite
challenging,
precluding
pharmacologic
demonstration
targets
in
vivo.
The
aim
this
Perspective
furnish
an
updated
outlook
about
small-molecule
described
over
last
two
decades.
Structures,
activities,
vitro/in
vivo
specificity
discussed,
well
biological
assays
used.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(18)
Published: Jan. 15, 2024
Abstract
Mitochondria,
widely
known
as
the
energy
factories
of
eukaryotic
cells,
have
a
myriad
vital
functions
across
diverse
cellular
processes.
Dysfunctions
within
mitochondria
serve
catalysts
for
various
diseases,
prompting
widespread
demise.
Mounting
research
on
remedying
damaged
indicates
that
constitute
valuable
target
therapeutic
intervention
against
diseases.
But
less
clinical
practice
and
lower
recovery
rate
imply
limitation
traditional
drugs,
which
need
further
breakthrough.
Nanotechnology
has
approached
favorable
regiospecific
biodistribution
high
efficacy
by
capitalizing
excellent
nanomaterials
targeting
drug
delivery.
Mitochondria‐remedying
nanodrugs
achieved
ideal
effects.
This
review
elucidates
significance
in
cells
organs,
while
also
compiling
mortality
data
related
Correspondingly,
nanodrug‐mediate
strategies
applicable
mitochondria‐remedying
disease
are
detailed,
with
full
understanding
roles
dysfunction
advantages
nanodrugs.
In
addition,
future
challenges
directions
discussed.
conclusion,
this
provides
comprehensive
insights
into
design
development
nanodrugs,
aiming
to
help
scientists
who
desire
extend
their
fields
engage
interdisciplinary
subject.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
11(16)
Published: Feb. 21, 2024
Abstract
Cancer
cells
typically
display
redox
imbalance
compared
with
normal
due
to
increased
metabolic
rate,
accumulated
mitochondrial
dysfunction,
elevated
cell
signaling,
and
accelerated
peroxisomal
activities.
This
may
regulate
gene
expression,
alter
protein
stability,
modulate
existing
cellular
programs,
resulting
in
inefficient
treatment
modalities.
Therapeutic
strategies
targeting
intra‐
or
extracellular
states
of
cancer
at
varying
state
progression
trigger
programmed
death
if
exceeded
a
certain
threshold,
enabling
therapeutic
selectivity
overcoming
resistance
radiotherapy
chemotherapy.
Nanotechnology
provides
new
opportunities
for
modulating
their
excellent
designability
high
reactivity.
Various
nanomaterials
are
widely
researched
enhance
highly
reactive
substances
(free
radicals)
production,
disrupt
the
endogenous
antioxidant
defense
systems,
both.
Here,
physiological
features
described
challenges
illustrated.
Then,
that
classified
elaborated
upon
based
on
ability
target
regulations.
Finally,
future
perspectives
this
field
proposed.
It
is
hoped
review
guidance
design
nanomaterials‐based
approaches
involving
therapy,
especially
cancers
resistant
chemotherapy,
etc.